ArticleBritish journal of cancer2023

Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.